A few months after SK Life Science…
A few months after SK Life Science began rolling out [...]
Novo Nordisk has come up short in…
Novo Nordisk has come up short in two phase 3 [...]
A combination of Merck-partnered…
A combination of Merck-partnered sac-TMT and Keytruda led to a [...]
Eli Lilly’s latest high-profile…
Eli Lilly’s latest high-profile crossovers—which include a starry TV partnership [...]
Maryland is becoming the home away…
Maryland is becoming the home away from home for British [...]
The approval came “months earlier…
The approval came “months earlier than anticipated,” Pfizer’s Chief Oncology Officer, [...]
The FDA has opened an…
The FDA has opened an investigation into Takeda’s recombinant protein [...]
Cosette had been attempting to…
Cosette had been attempting to invalidate its $430 million buyout [...]
Some four years into Jemperli’s…
Some four years into Jemperli’s commercial life span, a rift [...]
A Novo Nordisk challenge has…
A Novo Nordisk challenge has driven Regen Doctors to voluntarily [...]